Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2003

View Archived Issues

Manufacturing process established for ProSavin

CAB-175 enters phase I testing

Hedgehog compounds to be studied for the treatment of ALS

Biosyn submits IND for HIV microbicide UC-781

Introgen and NCI enter CTA for development of Advexin

Preclinical studies support use of MT-103 for chronic lymphocytic leukemia

Wilex radioimmunotherapy enters clinical evaluation in biliary cancers

Nuvelo initiates phase II testing with alfimeprase in acute peripheral arterial occlusion

Aventis develops new tubulin polymerization inhibitors

Dr. Reddy's presents new PPARalpha agonists in recent patent

Tularik and Roche describe novel IKK inhibitors and their use

AstraZeneca claims new IGF-1R modulators with utility in cancer therapy

Calyx patent covers new agents for diabetes, inflammation, etc.

New antibacterial oxazolidinones designed by Merck and Kyorin team

New urokinase inhibitors under study at Corvas

U.K. approval for Testim

Promising phase II findings for Alzhemed in Alzheimer's disease

Serostim not recommended for short bowel syndrome

Onyx prioritizes Bay-43-9006 program, discontinues therapeutic virus program

Aventis and Zealand sign licensing agreement for ZP-10

ETC-216 produces regression of atherosclerosis

European phase III phenserine trial gets under way

Four new trials expand evaluation of Genasense

FDA approves Pravigard PAC

Anidulafungin NDA accepted for review

Selective human histamine H4 receptor ligand discovered by international team

Orally active KCNQ2 channel opener with potential in the treatment of migraine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...